Wire Stories
754AM Best Affirms Credit Ratings of Central Reinsurance Corporation
HONG KONG–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” of...
- 775
AM Best Affirms Credit Ratings of Thaire Life Assurance Public Company Limited
SINGAPORE–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” of Thaire...
- 727
Global Dental Rapid Prototyping Systems Market to Surpass US$ 7,243.7 Million by 2027, Says Coherent Market Insights (CMI)
SEATTLE–(BUSINESS WIRE)–#DentalPrototyping–According to Coherent Market Insights, the global dental rapid prototyping systems market is estimated to be valued at US$ 1,824.9 million...
- 1.1K
Kyowa Kirin Receives Positive CHMP Opinion for the Expanded Use of CRYSVITA® (burosumab) to Include Older Adolescents and Adults for the Treatment of X-Linked Hypophosphataemia (XLH)
XLH is a rare, life-long genetic disease that causes abnormalities in the bones, muscles and joints1,2,3 TOKYO–(BUSINESS WIRE)–Kyowa Kirin Co., Ltd. (TSE:4151,...
- 705
Indonesian Telecoms Industry Report 2020-2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Indonesia Telecoms Industry Report 2020-2025” report has been added to ResearchAndMarkets.com’s offering. This report provides analyses of revenue and market...
- 823
S&P reaffirmed Guotai Junan International’s BBB+ Long-term Issuer Rating
HONG KONG–(BUSINESS WIRE)–Guotai Junan International Holdings Limited (“Guotai Junan International”, the “Company”, stock code:1788) is pleased to announce that Standard & Poor’s...
- 810
CSOP CSI 300 Index Daily (2X) Leveraged Product (ticker:7233.HK) and CSOP CSI 300 Index Daily (-1X) Inverse Product (ticker:7333.HK) to List on the HKEX
HONG KONG–(BUSINESS WIRE)–Hong Kong’s largest leveraged and inverse products (L&I products) issuer1, CSOP Asset Management Limited (“CSOP”) is proud to announce the...
- 806
EpimAb Biotherapeutics Strengthens Scientific Advisory Board with Addition of Professor Mark Smyth
SHANGHAI, China–(BUSINESS WIRE)–EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, today announced the appointment of Professor Mark Smyth to...
- 809
Likee, the Biggest Rival of TikTok, Partners with Believe Digital Bringing a Library of Millions of Songs to Users
SINGAPORE–(BUSINESS WIRE)–Users of Likee – the wildly popular short video app – have even more to sing and dance with thanks to...
- 841
Aroa Biosurgery Commences Trading on the ASX
HIGHLIGHTS Aroa lists on the ASX today after raising $45m at $0.75/share with an indicative market capitalisation of A$225m under the code...
